Abstract Purpose of Review To highlight the breadth and types of mental distress
experienced by hematopoietic stem cell transplant (HSCT) patients and highlight the need …

Delirium commonly occurs during myeloablative hematopoietic stem cell transplantation
(HCT). Little is known about how delirium during the acute phase of HCT affects long-term …

Purpose To determine the impact of delirium during the acute phase of myeloablative
hematopoietic stem-cell transplantation (HSCT) on health-related quality of life (HRQOL) …

BACKGROUND Delirium is common in patients undergoing hematopoietic stem cell
transplantation (HSCT) and is associated with considerable morbidity and excess mortality …

Background Delirium is common following hematopoietic stem-cell transplantation (HSCT)
and is associated with increased morbidity and mortality. Early recognition and treatment …

Purpose To determine pre-and post-transplantation risk factors for delirium onset and
severity during the acute phase of myeloablative hematopoietic stem-cell transplantation …

Delirium has been associated with a high risk of mortality in medical patients. Despite the
high incidence of delirium in patients who undergo hemapoietic stem cell transplantation …

BACKGROUND Delirium is common in patients with malignant disease and is associated
with significant morbidity. Studies have not examined the epidemiology of delirium in …

Background Delirium is a common complication of myeloablative hematopoietic stem-cell
transplantation (HSCT), yet no studies have explored the later effects of an episode of …

Delirium, a common neuropsychiatric syndrome among hospitalized patients, has been
associated with significant morbidity and mortality in patients undergoing hematopoietic …